 foscarnet sodium cytomegaloviru cmv major opportunist viral pathogen diseas immunocompromis patient organ transplant recipi peopl aid pneumon gastrointestin diseas enceph common manifest patient aid retin untreat retin necrosi ganciclovir sodium licens antivir agent treatment cmv retin infect major aid patient signific granulocytopenia thrombocytopenia therapi clinic applic myelosuppress aid patient agent zidovudin trimethoprim/sulfamethoxazol necessit dosag reduct discontinu agent patient ganciclovir foscarnet sodium pyrophosph analog activ cytomegaloviru human immunodefici viru type hiv effect altern manag cmv retin trial intraven foscarnet cmv retin favor result initi daili dose mg/kg/d intermitt infus hour mainten regimen mg/kg/d singl daili one- two-hour infus foscarnet therapi renal impair intraven mainten therapi recurr cmv infect drawback foscarnet lack major myelosuppress toxic activ hiv replic safe effect altern agent manag cmv infect aid patient